Synapse - Elsevier Inc.

Elsevier Inc.

SHERPA: Unknown

People

Giralt
Landau
Chung
Hassoun
Lesokhin
Devlin
Young

Groups

Bone Marrow Transplant (3)
Center for Hematologic Malignancies (3)
Department of Medicine (3)
Hematologic Malignancies, Division of (3)
Myeloma (3)
Survivorship Research (3)
Hematologic Malignancies Research (2)
Biostatistics Service (1)
Epidemiology and Biostatistics (1)

Search Within

Results (3)

Export to EndNote / Excel

T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches

Meeting Abstract

Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM)

Meeting Abstract

Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y. B.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S. A.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Immune reconstitution after autologous stem cell transplantation for multiple myeloma

Meeting Abstract

Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Wu, V.; Hassoun, H.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Koehne, G.; Giralt, S. A.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Elsevier Inc.

People

Groups

Results (3)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Elsevier Inc. – authorized name for: